Open Label Tolerability and Safety Study of KRX-101 in Australia, New Zealand, and Hong Kong

Clinical trial NCT00462202 · TERMINATED

Trial details

NCT number: NCT00462202
Sponsor: Keryx Biopharmaceuticals
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetic Nephropathy

Start date: 2007-04-01
Primary completion: 2008-03-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.